<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> have been extensively investigated, little is known about their circulating cytokine patterns </plain></SENT>
<SENT sid="1" pm="."><plain>We compared plasma soluble cytokines in 33 <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 57 <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> patients, and 48 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>High levels of thrombopoietin and granulocyte colony-stimulating factor, with low levels of CD40 ligand, chemokine (C-X-C motif) ligand 5, chemokine (C-C motif) ligand 5, chemokine (C-X-C motif) ligand 11, epidermal growth factor, vascular endothelial growth factor, and chemokine (C-C motif) ligand 11 were a signature profile for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>High levels of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-Î±, interleukin-6, chemokine (C-C motif) ligand 3, interleukin-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, and hepatocyte growth factor were a cytokine signature for <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Despite similar clinical presentations, distinct cytokine profiles were observed between <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and hypocellular <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Future studies focusing on cytokines that better discriminate these two entities such as thrombopoietin and chemokine (C-C motif) ligand 3 may be useful tools in clinical practice </plain></SENT>
</text></document>